Analyze Diet

Topic:Prophylaxis

Prophylaxis in horses refers to the preventive measures and strategies implemented to protect equine health by reducing the risk of disease occurrence. These measures can include vaccinations, parasite control, nutrition management, and biosecurity practices. Vaccinations help to stimulate the horse's immune system to protect against specific infectious diseases. Parasite control programs aim to minimize the impact of internal and external parasites through strategic deworming and environmental management. Nutrition management ensures that horses receive balanced diets that support their overall health and immune function. Biosecurity practices involve procedures to prevent the introduction and spread of infectious agents within equine populations. This page gathers peer-reviewed research studies and scholarly articles that explore various prophylactic approaches, their implementation, and their effectiveness in maintaining equine health.
Prevention of postoperative infections in horses.
The Veterinary clinics of North America. Equine practice    August 3, 2006   Volume 22, Issue 2 323-viii doi: 10.1016/j.cveq.2006.03.002
Santschi EM.The best defense against postoperative infection is to use multiple strategies to minimize wound contamination, maintain wound tissue health, and provide rational antimicrobial strategies that do not promote the development of resistant bacteria and superinfections.
Meningitis and encephalomyelitis in horses.
The Veterinary clinics of North America. Equine practice    August 3, 2006   Volume 22, Issue 2 553-x doi: 10.1016/j.cveq.2006.03.003
Pellegrini-Masini A, Livesey LC.This article provides an overview of meningitis and encephalomyelitis in horses, including diagnostic tests, treatment developments, and preventative measures reported in the equine and human medical literature of the past few years.
Pathophysiology, diagnosis, and management of urinary tract infection in horses.
The Veterinary clinics of North America. Equine practice    August 3, 2006   Volume 22, Issue 2 497-x doi: 10.1016/j.cveq.2006.03.004
Frye MA.Equine urinary tract infection (UTI) most commonly occurs as a sequela to structural or functional inhibition of normal urine flow. Although it is an infrequent diagnosis in equids, the incidence of UTI in human beings is high and has inspired great investigative effort. The resultant findings with potentially broad application as well as current equine studies are reviewed here. Recent developments in the understanding of host-agent interactions and renal defense mechanisms, emerging antimicrobial resistance, and novel therapeutic alternatives to prophylactic antibiotic use are emphasized.
Getting a grip on strangles: recent progress towards improved diagnostics and vaccines.
Veterinary journal (London, England : 1997)    July 3, 2006   Volume 173, Issue 3 492-501 doi: 10.1016/j.tvjl.2006.05.011
Waller AS, Jolley KA.'Strangles', caused by infection with the bacterium Streptococcus equi, remains one of the most commonly diagnosed and important infectious diseases of horses world-wide. This review discusses the diagnosis and pathogenesis of strangles with particular attention to the significance of persistent infections in disease transmission and the rapid progress now being made towards the development of effective preventative vaccines. It is now possible combine recent sequence data from the N-terminal region of the SeM protein and reassign the SeM alleles using the on-line database http://pubmlst.org/s...
Immunogenicity of synthetic Rhodococcus equi virulence-associated protein peptides in neonate foals.
International journal of medical microbiology : IJMM    June 19, 2006   Volume 296, Issue 6 389-396 doi: 10.1016/j.ijmm.2006.02.020
Cauchard J, Taouji S, Sevin C, Duquesne F, Bernabé M, Laugier C, Ballet JJ.Rhodococcus equi infection is considered the most common cause of pneumonia in foals less than 6 months of age. Immunization of foals and/or mares may become a procedure of choice for prevention. The present work documents the antibody response of neonate foals to R. equi virulence-associated protein (Vap) vaccine candidate peptides. A mixture of 4 R. equi (ATCC 33701) Vap peptides was selected based on their hydrophilicity and recognition by naturally acquired IgG antibodies from 13 adult horses and 33 neonate foals from France and Japan. They were combined with a water-based nanoparticular a...
West Nile virus in the United States (1999-2005).
Journal of the American Animal Hospital Association    April 14, 2006   Volume 42, Issue 3 170-177 doi: 10.5326/0420170
Gerhardt R.The accidental introduction of West Nile Virus into New York City from the Old World in 1999 resulted in an epidemic in humans, horses, and birds that swept to the west coast in just 3 years. The virus is transmitted by infective mosquitoes among susceptible native birds, which serve as amplifying hosts. Clinical disease occurs in humans and horses, but not enough virus is produced in their blood to infect other mosquitoes; therefore, humans and horses are considered dead-end hosts. Humans can best protect themselves by remaining indoors during periods of high mosquito activity and/or by using...
New therapeutic approaches for equine protozoal myeloencephalitis: pharmacokinetics of diclazuril sodium salts in horses.
Veterinary therapeutics : research in applied veterinary medicine    April 7, 2006   Volume 7, Issue 1 52-72 
Dirikolu L, Karpiesiuk W, Lehner AF, Hughes C, Woods WE, Harkins JD, Boyles J, Atkinson A, Granstrom DE, Tobin T.Diclazuril is a triazine-based antiprotozoal agent which may have clinical application in the treatment of equine protozoal myeloencephalomyelitis (EPM). In this study, the use of the sodium salt diclazuril to increase the apparent bioavailability of diclazuril for the treatment and prophylaxis of EPM and various other Apicomplexan mediated diseases is described. In this study, diclazuril sodium salt was synthesized and administered to horses as diclazuril sodium salt formulations. The absorption, distribution, and clearance of diclazuril sodium salt in the horse are described. Diclazuril was ...
Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab’)2 in mice.
Respiratory research    March 23, 2006   Volume 7, Issue 1 43 doi: 10.1186/1465-9921-7-43
Lu J, Guo Z, Pan X, Wang G, Zhang D, Li Y, Tan B, Ouyang L, Yu X.Avian influenza virus H5N1 has demonstrated considerable pandemic potential. Currently, no effective vaccines for H5N1 infection are available, so passive immunotherapy may be an alternative strategy. To investigate the possible therapeutic effect of antibody against highly pathogenic H5N1 virus on a mammal host, we prepared specific equine anti-H5N1 IgGs from horses vaccinated with inactivated H5N1 virus, and then obtained the F(ab')2 fragments by pepsin digestion of IgGs. Methods: The horses were vaccinated with inactivated H5N1 vaccine to prepare anti-H5N1 IgGs. The F(ab')2 fragments were p...
Survey on the subject of equine Lyme borreliosis.
International journal of medical microbiology : IJMM    March 9, 2006   Volume 296 Suppl 40 274-279 doi: 10.1016/j.ijmm.2006.01.004
Gall Y, Pfister K.According to the results of a questionnaire on equine Lyme borreliosis addressing veterinarians in Germany, the existence of the disease was confirmed by more than half of the 118 participants. Practitioners who regarded Borrelia burgdorferi as a pathogen of horses seemed to be more sensitized in terms of the number of annually diagnosed cases as well as the frequency of occurrence of tick infestation with equine patients or prophylactic treatments against ectoparasites by horse owners. Chronically poor performance and diverse orthopaedic problems were the clinical symptoms most often leading ...
Vaccination against equine influenza: quid novi?
Vaccine    February 28, 2006   Volume 24, Issue 19 4047-4061 doi: 10.1016/j.vaccine.2006.02.030
Paillot R, Hannant D, Kydd JH, Daly JM.Equine influenza virus is a leading cause of respiratory disease in the horse. Equine influenza vaccines containing inactivated virus were first developed in the 1960s. Despite their intensive use, equine influenza outbreaks still continue to occur and therefore new strategies of vaccination are necessary to improve vaccine efficacy. Numerous methods of vaccination have been evaluated and commercialised in the horse, the most recent being the cold-adapted influenza virus and poxvirus-based vaccines. As a large animal model, the horse is also a useful species in which to evaluate the potential ...
Mucosal and systemic adjuvant activity of alphavirus replicon particles.
Proceedings of the National Academy of Sciences of the United States of America    February 27, 2006   Volume 103, Issue 10 3722-3727 doi: 10.1073/pnas.0600287103
Thompson JM, Whitmore AC, Konopka JL, Collier ML, Richmond EM, Davis NL, Staats HF, Johnston RE.Vaccination represents the most effective control measure in the fight against infectious diseases. Local mucosal immune responses are critical for protection from, and resolution of, infection by numerous mucosal pathogens. Antigen processing across mucosal surfaces is the natural route by which mucosal immunity is generated, as peripheral antigen delivery typically fails to induce mucosal immune responses. However, we demonstrate in this article that mucosal immune responses are evident at multiple mucosal surfaces after parenteral delivery of Venezuelan equine encephalitis virus replicon pa...
Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse.
Vaccine    February 23, 2006   Volume 24, Issue 19 4144-4151 doi: 10.1016/j.vaccine.2006.02.016
Flock M, Karlström A, Lannergård J, Guss B, Flock JI.A mouse model resembling Streptococcus equi subspecies equi infection in the horse, strangles, was used to assess the protective effect of vaccination with selected recombinant proteins from S. equi subsp. equi. After challenge the infection was monitored by weight loss and by nasal colonisation with S. equi subsp. equi. Vaccination with a collagen-binding protein (CNE) and a collagen-like protein (SclC) resulted in protective antibodies, whereas a novel fibronectin-binding protein (FNEB) did not. Co-administration of CNE with EAG, a poorly immunogenic alpha2-macroglobulin-, albumin- and immun...
Effect of different adjuvants in equines for the production of equine rabies immunoglobulin.
The National medical journal of India    February 18, 2006   Volume 18, Issue 6 289-292 
Arora S, Sharma S, Goel SK, Singh US.Implementation of the recommended post-exposure prophylaxis by vaccination and specific immunoglobulin therapy for rabies is largely hampered by its high cost and inadequate production. Therefore, the development and availability of an economic preparation of rabies immunoglobulin is a high priority for India, where rabies is a major cause of death. We studied the efficacy of four different adjuvants in raising antibodies to rabies antigen in older, discarded equines. Methods: Eleven equines, 23-26 years old, were divided into 4 groups to receive four different adjuvants in small amounts (1-2 ...
The equine immune response to equine herpesvirus-1: the virus and its vaccines.
Veterinary immunology and immunopathology    February 14, 2006   Volume 111, Issue 1-2 15-30 doi: 10.1016/j.vetimm.2006.01.005
Kydd JH, Townsend HG, Hannant D.Equine herpesvirus-1 (EHV-1) is an alphaherpesvirus which infects horses, causing respiratory and neurological disease and abortion in pregnant mares. Latency is established in trigeminal ganglia and lymphocytes. Immunity to EHV-1 lasts between 3 and 6 months. Current vaccines, many of which contain inactivated virus, have reduced the incidence of abortion storms in pregnant mares but individual animals, which may be of high commercial value, remain susceptible to infection. The development of effective vaccines which stimulate both humoral and cellular immune responses remains a priority. Uti...
Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Veterinary immunology and immunopathology    February 14, 2006   Volume 111, Issue 1-2 67-80 doi: 10.1016/j.vetimm.2006.01.010
Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.Horses are commonly vaccinated to protect against pathogens which are responsible for diseases which are endemic within the general horse population, such as equine influenza virus (EIV) and equine herpesvirus-1 (EHV-1), and against a variety of diseases which are less common but which lead to greater morbidity and mortality, such as eastern equine encephalomyelitis virus (EEE) and tetanus. This study consisted of two trials which investigated the antigenicity of commercially available vaccines licensed in the USA to protect against EIV, EHV-1 respiratory disease, EHV-1 abortion, EEE and tetan...
Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
Expert review of vaccines    February 3, 2006   Volume 5, Issue 1 119-131 doi: 10.1586/14760584.5.1.119
Rosas CT, Goodman LB, von Einem J, Osterrieder N.Infections of horses with equine herpesvirus type 1 (EHV-1) have garnered new attention over the last few years. Devastating outbreaks occurring worldwide, primarily of the neurologic form of the disease, have resulted in a reassessment of the control strategies, and particularly the prophylactic measures, that are necessary to keep the infection and spread of disease in check. Most of the available EHV-1 vaccines are based on preparations of inactivated virus, which are applied monovalently for prevention of EHV-1-caused abortion in pregnant mares or as part of multivalent vaccines to prevent...
Pyrantel pamoate resistance in horses receiving daily administration of pyrantel tartrate.
Journal of the American Veterinary Medical Association    January 24, 2006   Volume 228, Issue 1 101-103 doi: 10.2460/javma.228.1.101
Brazik EL, Luquire JT, Little D.16 horses treated daily with pyrantel tartrate (2.64 mg/kg [1.2 mg/lb], PO) as part of a prophylactic anthelmintic program. Results: Fecal worm egg counts (FWECs) were obtained on all 16 horses. Mean FWEC was 478 eggs/g (epg; range, 0 to 4,075 epg). Three of the 16 horses were responsible for 85% of the total fecal egg output for the herd on the day of sampling. Six horses had FWECs < 200 epg. Three horses that had arrived within 4 months of the sampling date had FWECs 100 epg (9 horses) were treated with pyrantel pamoate (6.6 mg/kg [3 mg/lb], PO), and 14 days later, the FWEC was repeated....
Antibody responses of mares to prepartum vaccination with Clostridium perfringens bacterin and beta2 toxin.
The Veterinary record    December 20, 2005   Volume 157, Issue 25 810-812 doi: 10.1136/vr.157.25.810
Timoney JF, Hartmann M, Fallon L, Fallon E, Walker J.No abstract available
Efficacy demonstration of tetanus vaccines by double antigen ELISA.
Pharmeuropa bio    December 13, 2005   Volume 2005, Issue 1 31-52 
Rosskopf U, Noeske K, Werner E.This paper describes a double antigen ELISA (DAE) for rapid, specific and reliable assessment of the antitetanus immune status of horses and sheep. Compared with the indirect ELISA, the double antigen ELISA has the advantage of species-independent testing of sera. Thanks to its test design, it is more specific since the detected antibodies are forced to bind tetanus toxoid twice. In addition, it is very sensitive to tetanus antibodies, enabling the detection of low antibody titres, in range which is relevant for the assessment of the protective status (tetanus toxin neutralising antibodies). T...
A single-chain fragment variable recombinant antibody against F5 fimbria of enterotoxigenic Escherichia coli inhibits agglutination of horse red blood cells induced by F5 protein.
Veterinary research communications    October 11, 2005   Volume 29, Issue 6 463-476 doi: 10.1007/s11259-005-1432-z
Bhaskaran S, Jay CM, Berghman LR, Wagner GG, Waghela SD.Bovine colibacillosis caused by enterotoxigenic Escherichia coli (ETEC) is a worldwide problem. Adhesion of ETEC to intestinal cell receptors mediated by the surface protein F5 fimbriae is the initial step in the establishment of colibacillosis. Prevention of ETEC F5(+) adhesion to enterocytes protects newborn calves against collibacillosis. On the enterocytes, the F5 fimbriae bind to a ganglioside that is also found on horse red blood cells. Thus, the presence of F5 fimbriae induces haemagglutination, which is useful as an indicator in a functional assay system. In this study, recombinant ant...
The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
Veterinary immunology and immunopathology    August 10, 2005   Volume 108, Issue 3-4 345-355 doi: 10.1016/j.vetimm.2005.06.009
Crouch CF, Daly J, Henley W, Hannant D, Wilkins J, Francis MJ.In horses, natural infection confers long lasting protective immunity characterised by mucosal IgA and humoral IgGa and IgGb responses. In order to investigate the potential of locally administered vaccine to induce a protective IgA response, responses generated by vaccination with an immunostimulating complex (ISCOM)-based vaccine for equine influenza (EQUIP F) containing A/eq/Newmarket/77 (H7N7), A/eq/Borlänge/91 (H3N8) and A/eq/Kentucky/98 (H3N8) using a systemic prime/mucosal boost strategy were studied. Seven ponies in the vaccine group received EQUIP F vaccine intranasally 6 weeks after...
Equine neonatal sepsis.
The Veterinary clinics of North America. Equine practice    July 30, 2005   Volume 21, Issue 2 273-v doi: 10.1016/j.cveq.2005.04.007
Sanchez LC.Neonatal infection remains a leading cause of morbidity and mortality in the equine industry, despite advances in prevention and treatment. Many factors can influence a foal's risk for the development of sepsis in the peripartum period. This article discusses those factors, causative organisms, and therapeutic options. Factors that influence prognosis and potential preventative strategies also are addressed.
Effect of daily administration of pyrantel tartrate in preventing infection in horses experimentally challenged with Sarcocystis neurona.
American journal of veterinary research    June 7, 2005   Volume 66, Issue 5 846-852 doi: 10.2460/ajvr.2005.66.846
Rossano MG, Schott HC, Kaneene JB, Murphy AJ, Kruttlin EA, Hines MT, Sellon DC, Patterson JS, Elsheikha HM, Dubey JP, Mansfield LS.To determine whether daily administration of pyrantel tartrate can prevent infection in horses experimentally challenged with Sarcocystis neurona. Methods: 24 mixed-breed specific-pathogen-free weanling horses, 10 adult horses, 1 opossum, and 6 mice. Methods: Sarcocystis neurona-naïve weanling horses were randomly allocated to 2 groups. Group A received pyrantel tartrate at the labeled dose, and group B received a nonmedicated pellet. Both groups were orally inoculated with 100 sporocysts/d for 28 days, 500 sporocysts/d for 28 days, and 1000 sporocysts/d for 56 days. Blood samples were collec...
Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training.
Journal of the American Veterinary Medical Association    May 24, 2005   Volume 226, Issue 10 1685-1688 doi: 10.2460/javma.2005.226.1685
McClure SR, White GW, Sifferman RL, Bernard W, Hughes FE, Holste JE, Fleishman C, Alva R, Cramer LG.To determine whether omeprazole oral paste administered at a dosage of 0.5 or 1 mg/kg (0.23 or 0.45 mg/lb), PO, every 24 hours would effectively prevent the recurrence of gastric ulcers in horses in race training. Methods: Prospective study. Methods: 135 horses. Methods: Horses with gastric ulcers were treated with omeprazole at a dosage of 4 mg/kg (1.8 mg/lb), PO, every 24 hours for 28 days. Horses in the dose selection portion of the study were sham dose treated or received 0.5 or 1 mg of omeprazole/kg, PO, every 24 hours for an additional 28 days. Horses in the dose confirmation portion of ...
Bacterial isolates and antimicrobial susceptibilities in equine bacterial ulcerative keratitis (1993–2004).
Equine veterinary journal    May 17, 2005   Volume 37, Issue 3 207-211 doi: 10.2746/0425164054530731
Keller RL, Hendrix DV.Bacterial ulcerative keratitis is a common and often vision-threatening problem in horses. Emerging bacterial resistance to commonly used topical antibiotics has been demonstrated. Previous antibiotic use may alter the antimicrobial susceptibility of bacterial isolates. Objective: To document aerobic bacterial isolates and associated bacterial susceptibilities from horses with ulcerative keratitis treated at the University of Tennessee between January 1993 and May 2004 and determine whether prior antibiotic therapy affected antimicrobial susceptibility of the isolates. Methods: Medical records...
A recombinant envelope protein vaccine against West Nile virus.
Vaccine    April 6, 2005   Volume 23, Issue 30 3915-3924 doi: 10.1016/j.vaccine.2005.03.006
Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA.West Nile (WN) virus is a flavivirus that first appeared in North America in 1999. Since then, more than 600 human deaths and 22,000 equine infections have been attributed to the virus in the United States. We expressed a truncated form of WN virus envelope (E) protein in Drosophila S2 cells. This soluble recombinant E protein was recognized by antibodies from naturally infected horses, indicating that it contains native epitopes. Mice and horses produced high-titer antibodies when immunized with recombinant E protein combined with aluminum hydroxide. Immunized mice were resistant to challenge...
Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies.
Journal of veterinary pharmacology and therapeutics    February 22, 2005   Volume 28, Issue 1 45-49 doi: 10.1111/j.1365-2885.2004.00624.x
Ensink JM, Bosch G, van Duijkeren E.Tissue chambers, implanted subcutaneously in the neck in six ponies, were inoculated with Streptococcus equi subsp. zooepidemicus in order to determine the clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine (TMP/SDZ) against this infection. The TMP/SDZ treatment consisted of one intravenous (i.v.) injection of 5 mg/kg TMP and 25 mg/kg SDZ and the same dose of TMP/SDZ per os (p.o.), both given 3 h before inoculation. The oral dose was then repeated every 12 h for 5 days. TMP/SDZ concentrations in tissue chamber fluid (TCF) were above 10 times MIC at the moment of inoc...
Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.
International journal of medical microbiology : IJMM    February 18, 2005   Volume 294, Issue 7 437-445 doi: 10.1016/j.ijmm.2004.09.011
Vanniasinkam T, Barton MD, Heuzenroeder MW.Rhodococcus equi is a significant pathogen in foals predominantly causing a pyogranulomatous bronchopneumonia. Many vaccine candidates have been tested for the prevention of R. equi disease in foals. However, none of these have been developed for widespread commercial use. Previous studies have shown that a Th1 immune response is imperative for the protection of foals against R. equi disease. In this study a DNA and a protein vaccine based upon the well-characterised R. equi virulence-associated protein VapA were developed. The vaccines were tested in the BALB/c murine model and the results sh...
Immunologic responses to West Nile virus in vaccinated and clinically affected horses.
Journal of the American Veterinary Medical Association    February 15, 2005   Volume 226, Issue 2 240-245 doi: 10.2460/javma.2005.226.240
Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, Stricklin JB, Dewell RD, Roach SD, Long RE, Albers SJ, Callan RJ....To compare neutralizing antibody response between horses vaccinated against West Nile virus (WNV) and horses that survived naturally occurring infection. Methods: Cross-sectional observational study. Methods: 187 horses vaccinated with a killed WNV vaccine and 37 horses with confirmed clinical WNV infection. Methods: Serum was collected from vaccinated horses prior to and 4 to 6 weeks after completion of an initial vaccination series (2 doses) and 5 to 7 months later. Serum was collected from affected horses 4 to 6 weeks after laboratory diagnosis of infection and 5 to 7 months after the first...
Principles of early wound management.
The Veterinary clinics of North America. Equine practice    February 5, 2005   Volume 21, Issue 1 45-vi doi: 10.1016/j.cveq.2004.11.005
Wilson DA.The equine practitioner can positively influence wound healing by dispensing appropriate treatment in the first few hours after injury. Positive actions in the early period include hemostasis, meticulous cleansing and debridement of the wound, the use of effective but nonirritating products to disinfect the wound, closure (if indicated)with minimal tension on the suture line, the judicious use of drains,and ensuring adequate tetanus protection. Furthermore, a thorough assessment of the wound and the patient in the initial period after trauma provides pertinent information on prognosis. Finally...
1 11 12 13 14 15 26